Natural Resources, School of
Date of this Version
Journal of Toxicology Volume 2015, Article ID 739746, 9 pages
The cyanobacterial neurotoxin 𝛽-N-methylamino-L-alanine (BMAA) is considered to be an “excitotoxin,” and its suggested mechanism of action is killing neurons. Long-termexposure to L-BMAAis believed to lead to neurodegenerative diseases including Parkinson’s and Alzheimer’s diseases and amyotrophic lateral sclerosis (Lou Gehrig’s disease). Objectives of this study were to determine the presumptive median lethal dose (LD50), the Lowest-Observed-Adverse-Effect Level (LOAEL), and histopathologic lesions caused by the naturally occurring BMAA isomer, L-BMAA, in mice. Seventy NIH Swiss Outbred mice (35 male and 35 female) were used. Treatment group mice were injected intraperitoneally with 0.03, 0.3, 1, 2, and 3mg/g body weight L-BMAA, respectively, and control mice were sham-injected.The presumptive LD50 of L-BMAA was 3mg/g BWand the LOAEL was 2mg/g BW.There were no histopathologic lesions in brain, liver, heart, kidney, lung, or spleen in any of the mice during the 14-day study. L-BMAA was detected in brains and livers in all of treated mice but not in control mice.Males injected with 0.03mg/g BW, 0.3mg/g BW, and 3.0mg/g BW L-BMAA showed consistently higher concentrations (P < 0.01) in brain and liver samples as compared to females in those respective groups.
Natural Resources and Conservation Commons, Natural Resources Management and Policy Commons, Other Environmental Sciences Commons
Copyright © 2015 Maitham Ahmed Al-Sammak et al.